Polymyositis-dermatomyositis-associated interstitial lung disease.
about
Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy reviewInterstitial lung disease: progress and problemsTreatment of inflammatory myopathy: emerging therapies and therapeutic targetsRecent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory MyopathiesIdiopathic interstitial pneumonias with connective tissue diseases features: A reviewClinical advances in the diagnosis and therapy of the interstitial lung diseases.Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.New Insights into Antisynthetase SyndromeRheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic patternPatients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung functionDermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo, Brazil.Classification of idiopathic interstitial pneumonias: making sense of the alphabet soup.Cutaneous Connective Tissue Diseases: Epidemiology, Diagnosis, and Treatment.Nonspecific interstitial pneumonia: clinical associations and outcomesTuberculosis, lung infections, interstitial lung disease, and socioeconomic issues in AJRCCM 2001.Spontaneous pneumomediastinum: an unusual but serious complication of dermatomyositisIdiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?Pulmonary complications of inflammatory myopathy.Idiopathic inflammatory myopathy: autoantibody update.[Organizing pneumonia revealing a polymyositis]Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosisPrognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control studyClinical characteristics and survival in idiopathic pulmonary fibrosis and connective tissue disease-associated usual interstitial pneumonia.Autoimmune-featured interstitial lung disease: a distinct entity.Brief report: antisynthetase syndrome-associated myocarditisIncidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres.Treatment response and long term follow-up results of nonspecific interstitial pneumoniaNeuromuscular disorders and sleep.The respiratory system in connective tissue disorders.Challenges in pulmonary fibrosis x 5: the NSIP/UIP debate.Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activityPolymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants.Non-specific interstitial pneumonia; as the first clinical presentation of various collagen vascular disorders.Connective Tissue Disease-associated Interstitial Lung Disease: A review.The organizing pneumonias : a critical review of current concepts and treatment.Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease
P2860
Q24641813-1FBAA7EC-44C0-4D77-85F1-8E6610C05FABQ24655716-E612FE44-39DC-4939-B0EE-942A57571AC6Q26796546-D335579D-9E66-404B-AAA0-877004EF525BQ26798023-ECA24572-4D21-437D-8330-5CCB7CD0E585Q26799465-D0273034-A7EB-4122-8FAE-357ED086BB28Q33214781-06AC5FAC-C49A-4502-B13C-CBB3336B1EA8Q33395966-FA67DEFE-E17A-4628-921E-F45C2459B469Q33397195-B852381A-CEED-4066-8C15-384B541BFE2BQ33572873-111D8281-1B99-4E72-9D59-04751B89DE16Q33639777-35AC1575-5862-4F7F-9883-A3F8ABA363E3Q33649923-2C9A877A-7BD4-419A-9807-AE7634E30F92Q33724819-1AEA3807-6B4D-4D5B-B13C-AD92FC7C2519Q34098032-1209A2A3-0BB1-4C86-8191-BF995ED1FF0DQ34140461-61D61D85-A2D8-4350-912B-C31445DC179DQ34156734-93CE0FE5-F238-4644-8107-01586DEB7D6BQ34466996-E962E986-AB87-4781-B804-83B4EEF93311Q34537674-9988E000-C542-44B1-BAF0-F62290533C54Q34550149-363BCDC4-9EC9-4AF3-959E-D77CF033DEC8Q34589370-9C6AB391-68C1-4BC4-853F-F44D941330FDQ34635659-DF3BC6EF-8D11-4F1D-8304-116029FBA9A1Q34824794-2B48DB79-61D9-4C99-81BC-F9528D391A53Q34824854-5E123274-0B6F-4D0A-8566-1BC7AA9C641DQ35110370-CFE6B5DF-CBAE-445C-9793-9A70833A5F87Q35149295-57509CA1-721A-4DF4-9D44-CD5C426576C8Q35195954-C8E1BC92-E7C8-4B00-AB61-18B9B753FAB5Q35290722-6C1F27D5-5CB5-4FD7-BB85-316B32D9ACCFQ35497224-BA1A0DFE-B136-4BC0-91A3-B12EBE0E00EDQ35618761-A1C810D5-3CAB-46B1-8632-10E00027FC74Q35761863-A3675F74-7BA0-4709-B99A-A34E1C48C484Q35910593-444E1B5D-B71F-48E7-A611-7C03BDF28761Q36014477-1EC3CC05-6A84-445A-8FB6-38A95CEFDA41Q36060102-69B4A323-FA11-4FE8-B22D-59ED300F19B1Q36117547-42E6FED7-36DE-4A38-AD6F-569B69F8A236Q36225469-2D534948-C64A-43F5-BA39-5046C26FCC5FQ36245680-769BABCA-9343-47D4-9082-526120306425Q36287545-4896391F-4B0B-474A-B985-A067D42848BCQ36311548-4F2BB7B5-985E-408D-A506-BE33102A36B0Q36363696-BCDA859E-DCA9-42EB-BD9B-D86732BB7A44Q36476633-1934A374-0583-4E20-A53B-C19CFD48C965Q36598562-EBBF6251-C459-44CC-8363-16B71E3CA738
P2860
Polymyositis-dermatomyositis-associated interstitial lung disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Polymyositis-dermatomyositis-associated interstitial lung disease.
@en
type
label
Polymyositis-dermatomyositis-associated interstitial lung disease.
@en
prefLabel
Polymyositis-dermatomyositis-associated interstitial lung disease.
@en
P2093
P2860
P1476
Polymyositis-dermatomyositis-associated interstitial lung disease.
@en
P2093
Douglas WW
Hartman RP
Hartman TE
Schroeder DR
Tazelaar HD
P2860
P304
P356
10.1164/AJRCCM.164.7.2103110
P407
P577
2001-10-01T00:00:00Z